HeartBeam PE Ratio 2020-2023 | BEAT

Current and historical p/e ratio for HeartBeam (BEAT) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HeartBeam PE ratio as of April 25, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

HeartBeam PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-25 1.97 0.00
2023-12-31 2.35 $-0.92 0.00
2023-09-30 2.15 $-1.24 0.00
2023-06-30 2.41 $-1.55 0.00
2023-03-31 2.27 $-1.82 0.00
2022-12-31 4.88 $-1.59 0.00
2022-09-30 3.90 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.054B $0.000B
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.573B 22.01
Inspire Medical Systems (INSP) United States $7.095B 0.00
IRhythm Technologies (IRTC) United States $3.623B 0.00
Axonics (AXNX) United States $3.399B 0.00
10x Genomics (TXG) United States $3.279B 0.00
Enovis (ENOV) United States $3.080B 23.40
Azenta (AZTA) United States $2.905B 236.77
Olink Holding AB (publ) (OLK) Sweden $2.789B 0.00
Hims & Hers Health (HIMS) United States $2.644B 0.00
Privia Health (PRVA) United States $2.156B 95.63
Schrodinger (SDGR) United States $1.738B 0.00
Omnicell (OMCL) United States $1.260B 30.82
Phreesia (PHR) United States $1.237B 0.00
Definitive Healthcare (DH) United States $0.854B 0.00
Standard BioTools (LAB) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Clover Health Investments (CLOV) United States $0.322B 0.00
Pulmonx (LUNG) United States $0.290B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
American Well (AMWL) United States $0.154B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.132B 0.00
TruBridge (TBRG) United States $0.116B 4.95
111 (YI) China $0.088B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00